X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
akt kinase (1) 1
androgen antagonists - pharmacology (1) 1
androgen receptor (1) 1
androgens (1) 1
androgens - metabolism (1) 1
antineoplastic agents - pharmacology (1) 1
antineoplastic combined chemotherapy protocols - pharmacology (1) 1
apoptosis (1) 1
article (1) 1
binding (1) 1
binding-proteins (1) 1
biochemistry & molecular biology (1) 1
biology (1) 1
biotechnology (1) 1
bms-754807 (1) 1
breast (1) 1
breast cancer (1) 1
cancer (1) 1
cannulae (1) 1
cattle (1) 1
cell death (1) 1
cell growth (1) 1
cell line, tumor (1) 1
cell proliferation (1) 1
cell proliferation - drug effects (1) 1
cell survival - drug effects (1) 1
chelating agents (1) 1
chelation (1) 1
chemistry (1) 1
chemistry, multidisciplinary (1) 1
combination (1) 1
copper (1) 1
corn (1) 1
dialysis (1) 1
diet (1) 1
digestibility (1) 1
dosage (1) 1
drugs (1) 1
dry matter (1) 1
enzalutamide (1) 1
ethylenediaminetetraacetic acids (1) 1
expression (1) 1
family (1) 1
feeds (1) 1
female (1) 1
fistulae (1) 1
humans (1) 1
igf system (1) 1
igf1r (1) 1
igf1r/ir inhibition (1) 1
igf2 signaling (1) 1
igfir/ir inhibition (1) 1
index medicus (1) 1
inhibition (1) 1
insulin (1) 1
insulin-like growth factor ii (1) 1
insulin-like growth factor ii - metabolism (1) 1
insulin-like growth factor-2 (1) 1
insulin-like growth factors (1) 1
ir inhibition (1) 1
mammography (1) 1
manganese (1) 1
molecular subtypes (1) 1
molecular targeted therapy (1) 1
nvp-aew541 (1) 1
pathways (1) 1
patients (1) 1
phenylthiohydantoin - analogs & derivatives (1) 1
phenylthiohydantoin - pharmacology (1) 1
pyrazoles - pharmacology (1) 1
pyrimidines - pharmacology (1) 1
pyrroles - pharmacology (1) 1
receptor, igf type 1 - antagonists & inhibitors (1) 1
receptor, igf type 1 - metabolism (1) 1
receptors (1) 1
rumen (1) 1
signal transduction - drug effects (1) 1
solubility (1) 1
steam (1) 1
sulfate (1) 1
target recognition (1) 1
therapies (1) 1
trace minerals (1) 1
triazines - pharmacology (1) 1
triple negative breast neoplasms - drug therapy (1) 1
triple negative breast neoplasms - metabolism (1) 1
triple negative breast neoplasms - pathology (1) 1
triple-negative breast cancer (1) 1
viability (1) 1
zinc (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of Animal Science, ISSN 0021-8812, 04/2019, Volume 97, Issue 4, pp. 1852 - 1864
Abstract Eight crossbred steers (BW 719.0 ± 65.0 kg) with ruminal and duodenal cannulae were used to examine the effect of trace mineral (TM) source on... 
Journal Article
Journal of Animal Science, ISSN 0021-8812, 04/2019, Volume 97, Issue 4, pp. 1852 - 1864
Eight crossbred steers (BW 719.0 ± 65.0 kg) with ruminal and duodenal cannulae were used to examine the effect of trace mineral (TM) source on digestibility;... 
Binding | Solubility | Corn | Fistulae | Dry matter | Rumen | Trace minerals | Dosage | Zinc | Diet | Ethylenediaminetetraacetic acids | Cattle | Steam | Chelation | Dialysis | Chelating agents | Sulfate | Copper | Feeds | Cannulae | Digestibility | Manganese
Journal Article
International Journal of Molecular Sciences, ISSN 1661-6596, 11/2017, Volume 18, Issue 11, p. 2305
Triple-negative breast cancer (TNBC) occurs in 10-15% of all breast cancer patients, yet it accounts for about half of all breast cancer deaths. There is an... 
BMS-754807 | IGFIR/IR inhibition | AKT kinase | Androgen receptor | NVP-AEW541 | Insulin-like growth factor-2 | Enzalutamide | Apoptosis | IGF2 signaling | Triple-negative breast cancer | MOLECULAR SUBTYPES | PATHWAYS | triple-negative breast cancer | BIOCHEMISTRY & MOLECULAR BIOLOGY | insulin-like growth factor-2 | apoptosis | COMBINATION | CHEMISTRY, MULTIDISCIPLINARY | BINDING-PROTEINS | IGF1R | FAMILY | IGF SYSTEM | androgen receptor | DRUGS | IR inhibition | THERAPIES | EXPRESSION | enzalutamide | Phenylthiohydantoin - pharmacology | Cell Survival - drug effects | Receptor, IGF Type 1 - metabolism | Receptor, IGF Type 1 - antagonists & inhibitors | Triazines - pharmacology | Humans | Androgen Antagonists - pharmacology | Pyrimidines - pharmacology | Molecular Targeted Therapy | Triple Negative Breast Neoplasms - drug therapy | Insulin-Like Growth Factor II - metabolism | Phenylthiohydantoin - analogs & derivatives | Antineoplastic Combined Chemotherapy Protocols - pharmacology | Pyrroles - pharmacology | Signal Transduction - drug effects | Triple Negative Breast Neoplasms - metabolism | Triple Negative Breast Neoplasms - pathology | Cell Line, Tumor | Female | Antineoplastic Agents - pharmacology | Cell Proliferation - drug effects | Androgens - metabolism | Pyrazoles - pharmacology | Cell proliferation | Biotechnology | Target recognition | Mammography | Breast cancer | Insulin-like growth factors | Insulin | Patients | Receptors | Androgens | Cell growth | Cell death | Breast | Inhibition | Insulin-like growth factor II | Viability | Cancer | IGF1R/IR inhibition
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.